If you are a company with (or recently had) an HHS SBIR or STTR Phase II funding award, or if you are a university working on a STTR-funded project with such a company, you may want to have the small business awardee consider applying to the NIH Commercialization Accelerator Program (CAP) for HHS SBIR/STTR Phase II Awardees.
OPEN FOR APPLICATIONS UNTIL AUGUST 31, 2017 11:59pm PDT
Basically, the NIH CAP is a 9-month commercialization mentoring/training program that is Free to selected HHS Phase II SBIR/STTR awardees (e.g., NIH, CDC, FDA grant or contract Phase II SBIR/STTR awardees) who apply and are selected for CAP. The small business can learn and work on developing tools, strategic plans, and/or other relevant approaches for achieving successful commercialization and readiness for market opportunities of their HHS SBIR/STTR-funded technologies. Please note that this program provides technical assistance, but it is not a funding program.
Application Deadline:
- August 31 2017 11:59pm (PDT)
Eligibility Highlights:
- SBIR or STTR Phase II Funding Award Recipient (either a grant or contract) from HHS (e.g., NIH, CDC, FDA)
- Said Funding Award is Currently Active OR the project was active anytime from August 2012 to the present (Awards ending before August 2012 are not eligible)
- For more information on eligibility and other aspects/information about the program, and how to Apply, please check at:
- To Apply to NIH CAP, Click here à https://portal.larta.org/registration/nih
- NIH CAP website: https://sbir.nih.gov/cap
- Catch the Info Webinar: https://register.gotowebinar.com/register/555955244818989827
- To Apply to NIH CAP, Click here à https://portal.larta.org/registration/nih
Need Help?
We would love to talk with you. Please feel free to schedule a consultation call at https://www.ebhoward.com/contact/
Ready To Take the Next Step?
We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.